0001437749-17-014930.txt : 20170817 0001437749-17-014930.hdr.sgml : 20170817 20170817090346 ACCESSION NUMBER: 0001437749-17-014930 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170816 FILED AS OF DATE: 20170817 DATE AS OF CHANGE: 20170817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASADORIAN RAFFI CENTRAL INDEX KEY: 0001628970 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 171037734 MAIL ADDRESS: STREET 1: TBD STREET 2: TBD CITY: TBD STATE: CA ZIP: 99999 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 3 1 rdgdoc.xml FORM 3 NO HOLDINGS X0206 3 2017-08-16 1 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001628970 ASADORIAN RAFFI C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Chief Financial Officer /s/ Martha Adler, Attorney-in-Fact 2017-08-17